Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combined therapy in children and adolescents with classical Hodgkin's lymphoma: A report from the SFCE on MDH-03 national guidelines.
Seror E, Donadieu J, Pacquement H, Abbou S, Lambilliotte A, Schell M, Curtillet C, Gandemer V, Pasquet M, Aladjidi N, Lutz P, Schmitt C, Deville A, Minckes O, Vanier JP, Armari-Alla C, Thomas C, Gorde-Grosjean S, Millot F, Blouin P, Garnier N, Coze C, Devoldere C, Reguerre Y, Helfre S, Claude L, Clavel J, Oberlin O, Landman-Parker J, Leblanc T. Seror E, et al. Among authors: gorde grosjean s. Pediatr Hematol Oncol. 2016 Oct-Nov;33(7-8):423-437. doi: 10.1080/08880018.2016.1247393. Pediatr Hematol Oncol. 2016. PMID: 27960645 Clinical Trial.
Outcome of children and adolescents with recurrent/refractory classical Hodgkin lymphoma, a study from the Société Française de Lutte contre le Cancer des Enfants et des Adolescents (SFCE).
Gorde-Grosjean S, Oberlin O, Leblanc T, Pacquement H, Donadieu J, Lambilliotte A, Schell M, Dommange F, Munzer M, Paillard C, Schmitt C, Lutz P, Edan C, Ansoborlo S, Stephan JL, Michel G, Thomas C, Perel Y, Robert A, Landman-Parker J. Gorde-Grosjean S, et al. Br J Haematol. 2012 Sep;158(5):649-56. doi: 10.1111/j.1365-2141.2012.09199.x. Epub 2012 Jul 4. Br J Haematol. 2012. PMID: 22757721 Free article.
Advanced stage nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents: clinical characteristics and treatment outcome - a report from the SFCE & CCLG groups.
Shankar AG, Roques G, Kirkwood AA, Lambilliotte A, Freund K, Leblanc T, Hayward J, Abbou S, Ramsay AD, Schmitt C, Gorde-Grosjean S, Pacquement H, Haouy S, Boudjemaa S, Aladjidi N, Hall GW, Landman-Parker J. Shankar AG, et al. Among authors: gorde grosjean s. Br J Haematol. 2017 Apr;177(1):106-115. doi: 10.1111/bjh.14518. Epub 2017 Feb 21. Br J Haematol. 2017. PMID: 28220934 Free article.
[New insights in Hodgkin's lymphoma biology].
Landman-Parker J, Gorde-Grosjean S. Landman-Parker J, et al. Among authors: gorde grosjean s. Arch Pediatr. 2009 Jun;16(6):667-8. doi: 10.1016/S0929-693X(09)74105-3. Arch Pediatr. 2009. PMID: 19541123 French. No abstract available.
Treatment outcome after low intensity chemotherapy [CVP] in children and adolescents with early stage nodular lymphocyte predominant Hodgkin's lymphoma - an Anglo-French collaborative report.
Shankar A, Hall GW, Gorde-Grosjean S, Hasenclever D, Leblanc T, Hayward J, Lambilliotte A, Daw S, Perel Y, McCarthy K, Lejars O, Coulomb A, Oberlin WO, Wallace WH, Landman-Parker J. Shankar A, et al. Among authors: gorde grosjean s. Eur J Cancer. 2012 Jul;48(11):1700-6. doi: 10.1016/j.ejca.2011.10.018. Epub 2011 Nov 15. Eur J Cancer. 2012. PMID: 22093944
Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma.
Mauz-Körholz C, Gorde-Grosjean S, Hasenclever D, Shankar A, Dörffel W, Wallace WH, Schellong G, Robert A, Körholz D, Oberlin O, Hall GW, Landman-Parker J. Mauz-Körholz C, et al. Among authors: gorde grosjean s. Cancer. 2007 Jul 1;110(1):179-85. doi: 10.1002/cncr.22762. Cancer. 2007. PMID: 17526010 Free article.